BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · IEX Real-Time Price · USD
+0.59 (0.77%)
At close: May 17, 2024, 4:00 PM
-1.55 (-2.00%)
After-hours: May 17, 2024, 7:09 PM EDT

BioMarin Pharmaceutical Statistics

Total Valuation

BMRN has a market cap or net worth of $14.74 billion. The enterprise value is $14.78 billion.

Market Cap 14.74B
Enterprise Value 14.78B

Important Dates

The last earnings date was Wednesday, April 24, 2024, after market close.

Earnings Date Apr 24, 2024
Ex-Dividend Date n/a

Share Statistics

BMRN has 189.88 million shares outstanding. The number of shares has increased by 2.52% in one year.

Shares Outstanding 189.88M
Shares Change (YoY) +2.52%
Shares Change (QoQ) +9.94%
Owned by Insiders (%) 0.84%
Owned by Institutions (%) 101.13%
Float 188.42M

Valuation Ratios

The trailing PE ratio is 73.17 and the forward PE ratio is 42.07. BMRN's PEG ratio is 0.76.

PE Ratio 73.17
Forward PE 42.07
PS Ratio 5.96
Forward PS 5.12
PB Ratio 2.90
P/FCF Ratio 76.83
PEG Ratio 0.76
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 41.07, with an EV/FCF ratio of 77.04.

EV / Earnings 71.93
EV / Sales 5.98
EV / EBITDA 41.07
EV / EBIT 58.06
EV / FCF 77.04

Financial Position

The company has a current ratio of 2.74, with a Debt / Equity ratio of 0.21.

Current Ratio 2.74
Quick Ratio 1.55
Debt / Equity 0.21
Debt / EBITDA 3.02
Debt / FCF 5.67
Interest Coverage 14.82

Financial Efficiency

Return on equity (ROE) is 4.20% and return on invested capital (ROIC) is 2.63%.

Return on Equity (ROE) 4.20%
Return on Assets (ROA) 3.00%
Return on Capital (ROIC) 2.63%
Revenue Per Employee $726,740
Profits Per Employee $60,410
Employee Count 3,401
Asset Turnover 0.37
Inventory Turnover 0.50


In the past 12 months, BMRN has paid $31.90 million in taxes.

Income Tax 31.90M
Effective Tax Rate 13.44%

Stock Price Statistics

The stock price has decreased by -15.94% in the last 52 weeks. The beta is 0.34, so BMRN's price volatility has been lower than the market average.

Beta (1Y) 0.34
52-Week Price Change -15.94%
50-Day Moving Average 85.45
200-Day Moving Average 88.60
Relative Strength Index (RSI) 32.11
Average Volume (30 Days) 1,597,750

Short Selling Information

The latest short interest is 3.91 million, so 2.06% of the outstanding shares have been sold short.

Short Interest 3.91M
Short Previous Month 3.69M
Short % of Shares Out 2.06%
Short % of Float 2.08%
Short Ratio (days to cover) 2.14

Income Statement

In the last 12 months, BMRN had revenue of $2.47 billion and earned $205.46 million in profits. Earnings per share was $1.06.

Revenue 2.47B
Gross Profit 1.96B
Operating Income 187.21M
Pretax Income 237.35M
Net Income 205.46M
EBITDA 359.85M
EBIT 254.53M
Earnings Per Share (EPS) $1.06
Full Income Statement

Balance Sheet

The company has $1.05 billion in cash and $1.09 billion in debt, giving a net cash position of -$41.38 million or -$0.22 per share.

Cash & Cash Equivalents 1.05B
Total Debt 1.09B
Net Cash -41.38M
Net Cash Per Share -$0.22
Equity / Book Value 5.07B
Book Value Per Share 26.72
Working Capital 1.90B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $280.16 million and capital expenditures -$88.34 million, giving a free cash flow of $191.82 million.

Operating Cash Flow 280.16M
Capital Expenditures -88.34M
Free Cash Flow 191.82M
FCF Per Share $1.02
Full Cash Flow Statement


Gross margin is 79.22%, with operating and profit margins of 7.57% and 8.31%.

Gross Margin 79.22%
Operating Margin 7.57%
Pretax Margin 9.60%
Profit Margin 8.31%
EBITDA Margin 14.56%
EBIT Margin 10.30%
FCF Margin 7.76%

Dividends & Yields

BMRN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.52%
Shareholder Yield -2.52%
Earnings Yield 1.39%
FCF Yield 1.30%
Dividend Details

Analyst Forecast

The average price target for BMRN is $105.90, which is 36.54% higher than the current price. The consensus rating is "Buy".

Price Target $105.90
Price Target Difference 36.54%
Analyst Consensus Buy
Analyst Count 22
Revenue Growth Forecast (5Y) 12.10%
EPS Growth Forecast (5Y) 50.42%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


BMRN has an Altman Z-Score of 5.62 and a Piotroski F-Score of 7.

Altman Z-Score 5.62
Piotroski F-Score 7